kabutan

Modalis Therapeutics, Last Fiscal Year's Net Income Loss Narrows, Current period performance is undisclosed.

Thu Feb 13, 2025 3:00 pm JST Earnings

4883 Modalis Therapeutics Corporation 【J-GAAP】

Earnings Report

Modalis Therapeutics Corporation <4883> [TSE Growth] announced its financial results in the afternoon session on February 13th (15:00). The consolidated net loss for the fiscal year ending December 2024 was loss of 1.31 billion yen, a reduction in the deficit compared to loss of 1.31 billion yen in the previous term. This marks the fifth consecutive term of losses. Furthermore, the company did not disclose the performance outlook for the fiscal year ending December 2025.

In the most recent three-month period, from October to December (4Q), the consolidated net loss improved to a deficit of 0.25 billion yen (compared to a loss of 0.81 billion yen in the same period last year).

Kabutan News

Actual Results

Historical Performance
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Dec, 2022 40 -2,063 -1,995 -2,702 -92.9 0 Feb 13, 2023 J-GAAP
Dec, 2023 0 -2,370 -2,351 -2,391 -77.2 0 Feb 14, 2024 J-GAAP
Dec, 2024 0 -1,337 -1,303 -1,317 -28.6 0 Feb 13, 2025 J-GAAP
YoY +43.6% +44.6% +44.9% +63.0%

Full Year Results vs. Previous Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Dec, 2024 Guidance 0 Feb 14, 2024 J-GAAP
Dec, 2024 Results 0 -1,337 -1,303 -1,317 -28.6 0 Feb 13, 2025 J-GAAP
Revision Rate

Current Period Guidance

H1 Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Jan - Jun, 2024 0 -838 -780 -780 -22.0 0 Aug 7, 2024 J-GAAP
Jan - Jun, 2025 Guidance 0 Feb 13, 2025 J-GAAP
YoY

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Dec, 2023 0 -2,370 -2,351 -2,391 -77.2 0 Feb 14, 2024 J-GAAP
Dec, 2024 0 -1,337 -1,303 -1,317 -28.6 0 Feb 13, 2025 J-GAAP
Dec, 2025 Guidance 0 Feb 13, 2025 J-GAAP
YoY

Quarterly Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Oct - Dec, 2023 0 -761 -809 -810 -26.2 -Inf Feb 14, 2024 J-GAAP
Jan - Mar, 2024 0 -490 -457 -457 -13.6 -Inf May 8, 2024 J-GAAP
Apr - Jun, 2024 0 -348 -323 -323 -9.1 -Inf Aug 7, 2024 J-GAAP
Jul - Sep, 2024 0 -224 -279 -280 -7.2 -Inf Nov 7, 2024 J-GAAP
Oct - Dec, 2024 0 -275 -244 -257 -5.6 -Inf Feb 13, 2025 J-GAAP
YoY +63.9% +69.8% +68.3% +78.7%

Related Articles